FAST NEWS: InnoCare Pharma’s Loss Soars on R&D Costs, Exchange Losses
The latest: InnoCare Pharma Ltd. (9969.HK) said it expects to report its net loss soared about 13 times to 910 million yuan ($134 million) last year, according to a profit…
RELATED ARTICLES
-
FAST NEWS: InnoCare inches closer to profitability on strong sales gains
9969.HK
-
FAST NEWS: InnoCare’s loss narrows on higher lymphoma drug sales
9969.HK
-
Kintor shares plunge after hair-loss drug flops in clinical trials
9939.HK
-
Akeso marks profit milestone with swift rights issue
9926.HK
-
AstraZeneca pays hefty price for Chinese weight-loss drug
AZN.US
-
Drug maker Junshi seeks Swiss cure for cash woes
1877.HK 688150.SHG
- HighTide Therapeutics places big IPO bet on “affluenza” drug
Discover hidden China stock gems in our weekly newsletter